RBC maintains Adams at sector perform

RBC Capital Markets analyst Ken Trbovich kept Adams Respiratory Therapeutics Inc. at its sector perform, above average risk, rating on news the company will repurchase the Fort Worth, Texas, manufacturing facility from Cardinal Health for $28 million in cash. The company will make a $24 million cash payment to Cardinal Health and pay the remaining $4 million over the course of 2007. Adams plans to finance the buyback using a combination of cash and debt. Shares of the Chester, N.J.-based pharmaceutical company were down $1.87, or 4.20%, at $42.64 on volume of 138,552 shares versus the three-month running average of 297,909 shares. (Nasdaq: ARXT)

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.